RARγ is a negative regulator of osteoclastogenesis
Alanna C. Green(University of Sheffield), Louise E. Purton(St Vincents Institute of Medical Research), K D Hausler(The University of Melbourne), Christina Vrahnas(The University of Melbourne), Ingrid J. Poulton(St Vincents Institute of Medical Research), Matthew T. Gillespie(Hudson Institute of Medical Research), Natalie A. Sims(The University of Melbourne), T. John Martin(St Vincent's Hospital Melbourne), J Quinn(The University of Melbourne), Joy Y. Wu(Cardiovascular Institute of the South), Roshantha A.S. Chandraratna(Allergan (United States)), Carl R. Walkley(Hudson Institute of Medical Research)
Cited by 29
Related Papers
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
|Endocrine Reviews|1999|2.3k
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
|Journal of Clinical Investigation|1999|1.7k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
|Endocrinology|1999|536